20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T40379 | Bax BH3 peptide (55-74), wild type | Bax BH3 peptide (55-74), wild type | |
Bax BH3 peptide (55-74), wild type is a 20-amino acid peptide (Bax 1) known for its ability to induce apoptosis in various cell line models. | |||
T9303 | MRTX1133 | Ras | |
MRTX1133 is a KRAS G12D inhibitor (KD=0.2 pM) that is potent, selective, and non-covalent. MRTX1133 exhibits inhibitory activity against KRAS G12D-mutated tumors, but not against KRAS wild-type tumors. | |||
T9246 | JNJ-63576253 | Androgen Receptor | |
JNJ-63576253 is a Clinical Stage Androgen Receptor Antagonist for F877L Mutant and Wild-Type Castration-Resistant Prostate Cancer (mCRPC). | |||
T1623 | Lopinavir | ABT-378 | SARS-CoV , HIV Protease |
Lopinavir (ABT-378) is a peptidomimetic HIV protease inhibitor that retains activity against HIV protease with the Val 82 mutation. Lopinavir is less affected by binding to serum proteins than the structurally-related dr... | |||
T8933 | JNJ-63576253 free base | TRC253,JNJ-63576253 | Androgen Receptor |
JNJ-63576253 free base (TRC253) is a potent and orally active full antagonist of androgen receptor (AR), with IC50s of 37 and 54 nM for F877L mutant AR and wild-type AR in LNCaP cells. JNJ-63576253 can be used for the re... | |||
T21900 | ML-336 | Others | |
ML-336 is an inhibitor of of the Venezuelan equine encephalitis virus (VEEV) strain TC-83. | |||
T3184 | Kevetrin hydrochloride | Thioureidobutyronitrile HCl,thioureido butyronitrile hydrochloride,4-Isothioureidobutyronitrile hydrochloride | Mdm2 , p53 |
Kevetrin hydrochloride (4-Isothioureidobutyronitrile hydrochloride) is a small molecule and activator of the tumor suppressor protein p53, with potential antineoplastic activity. | |||
T2330 | Rilpivirine | TMC278,R278474,DB08864 | HIV Protease , Reverse Transcriptase |
Rilpivirine (R278474) is a diarylpyrimidine derivative and reverse transcriptase inhibitor with antiviral activity against HIV-1 that is used in the treatment of HIV infections. | |||
T39202 | CZC-54252 hydrochloride | LRRK2 | |
CZC-54252 hydrochloride is a selective inhibitor of LRRK2 with IC50s of 1.85 nM and 1.28 nM for wild-type and G2019S LRRK2. CZC-54252 hydrochloride has a neuroprotective activity and attenuates G2019S LRRK2-induced human... | |||
T23182 | PPY A | Bcr-Abl | |
PPY A is a potent inhibitor of T315l mutant and wild-type Abl kinase (IC50 of 9 and 20 nM, respectively).PPY A also inhibits the growth of Bcr-Abl T315l mutant or wild-type Bcr-Abl genetically transformed cells. | |||
T32108 | HXJ42 | HXJ-42,HXJ 42 | Others |
HXJ42 is a PP1 analog that selectively and effectively acts on wild-type ZAP-70 (AS). | |||
T21946 | BIMU 8 | 5-HT Receptor | |
BIMU 8 is a selective agonist of 5-HT4 with EC50s of 18 nM, 77 nM, and 540 nM for wild-type 5HT4 receptor, T3.36A, and W6.48A mutant 5-HT4. | |||
T6824 | EAI045 | EGFR | |
EAI045, an allosteric inhibitor, targets towards drug-resistant EGFR mutants but avoids the wild-type receptor. | |||
T2620 | G-749 | G749 | Apoptosis , FLT , c-RET , TAM Receptor , Aurora Kinase |
G-749, a new-type FLT3 inhibitor, exhibits effective and sustained inhibition of the FLT3 wild type and mutants. | |||
T2050 | PF-06447475 | LRRK2 | |
PF-06447475 is a highly effective, specific, brain penetrant LRRK2 inhibitor with IC0 of 3/11 nM for wild type LRRK2 and G2019S LRRK2 respectively. | |||
T12097 | Morphothiadin | GLS4 | HBV |
Morphothiadin (GLS4) is a potent inhibitor on the replication of both wild-type and adefovir-resistant HBV (IC50 of 12 nM). | |||
T5139 | CZC-25146 hydrochloride | LRRK2 | |
CZC-25146 is a selective LRRK2 inhibitor with IC50 of 4.76 nM/6.87 nM for wild type LRRK2 and G2019S LRRK2, respectively. | |||
T13273 | UT-34 | Androgen Receptor | |
UT-34 is a selective and orally active antagonist of second-generation pan-androgen receptor (AR) and degrader(IC50s of 211.7 nM, 262.4 nM and 215.7 nM for wild-type, F876L and W741L AR, respectively), and has anti-prost... | |||
T7970 | 7-Ethoxycoumarin | Others | |
7-Ethoxycoumarin, a typical human P450 substrate, is catalyzed by both wild-type and mutant forms of CYP102A1. | |||
T4565 | Tafamidis | Fx-1006A | Others |
Tafamidis (Fx-1006A) is a kinetic stabilizer of transthyretin (TTR) that prevents amyloidogenesis by wild-type and mutant TTRs. It binds to TTR with negative cooperativity (Kd1: 3 nM; Kd2: 278 nM) to stabilize the TTR di... |